Effect of a new inhibitor of lipid peroxidation on kidney function after ischaemia-reperfusion. A study on rat and rabbit kidneys. 1996

V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
Department of Urology, Sablgrenska sjukhuset, University of Göteborg, Sweden.

Lipid peroxidation of mitochondrial and cell membrane structures is the final step in the oxygen radical-induced damage observed at reperfusion of kidneys after ischaemia. We compared the ability of an indeno-indol compound (code name H290/51) with that of alpha-tocopherol to inhibit lipid peroxidation in reoxygenated isolated rat renal tissue in vitro measured as production of TBARS (thiobarbituric acid reactive substances). H290/51 was 100 times more efficient than alpha-tocopherol. Treatment of rats in vivo with H290/51 in a dosage giving a plasma concentration of 500 nmol L-1 inhibited TBARS production measured in vitro by 80%. Treatment of rabbits with H290/51 almost completely inhibited radical production at reperfusion after 60 min of ischaemia measured with spin trap technique using OXANOH (2-ethyl-3-hydroxy-2,4,4-trimethyloxazolidine) as a spin trap. Furthermore, such pretreatment significantly improved kidney function and survival of rabbits subjected to 60 min of ischaemia to the left kidney and contralateral nephrectomy. These studies stress the importance of inhibiting lipid peroxidation to prevent the ischaemia-reperfusion damage and furthermore suggest a role for treatment with antioxidants like H290/51 in clinical practice, e.g. at reconstructive renal surgery and transplantation.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007677 Kidney Function Tests Laboratory tests used to evaluate how well the kidneys are working through examination of blood and urine. Function Test, Kidney,Function Tests, Kidney,Kidney Function Test,Test, Kidney Function,Tests, Kidney Function
D008353 Mannitol A diuretic and renal diagnostic aid related to sorbitol. It has little significant energy value as it is largely eliminated from the body before any metabolism can take place. It can be used to treat oliguria associated with kidney failure or other manifestations of inadequate renal function and has been used for determination of glomerular filtration rate. Mannitol is also commonly used as a research tool in cell biological studies, usually to control osmolarity. (L)-Mannitol,Osmitrol,Osmofundin
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004234 Diuretics, Osmotic Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma. Osmotic Diuretic,Osmotic Diuretics,Diuretic, Osmotic
D005260 Female Females
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical

Related Publications

V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
January 1996, Journal of lipid mediators and cell signalling,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
August 1995, Acta physiologica Scandinavica,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
January 1986, Comparative biochemistry and physiology. B, Comparative biochemistry,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
January 1986, Comparative biochemistry and physiology. B, Comparative biochemistry,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
March 1993, Neuropharmacology,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
June 1995, Journal of cardiovascular pharmacology,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
January 1990, Physiologia Bohemoslovaca,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
February 1999, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
January 1987, Free radical research communications,
V Sørensen, and U Nilsson, and S Pettersson, and T Scherstén, and P O Sjöqvist, and L Svensson, and O Jonsson
June 1998, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!